Headache & Migraine
Article
Effects of pausing migraine prophylaxis with CGRP-receptor mAb hint at therapy resumption
Article
Real-world value of fremanezumab therapy against migraine
Article
Fremanezumab efficacy against difficult-to-treat migraine is unperturbed by age or sex
Article
Erenumab improves work output in employed patients with migraine
Article
Noninvasive vagus nerve stimulation affirms its potential to prevent migraine
Article
Erenumab is an effective therapeutic option for migraine with aura
Literature Review
Ketamine nasal spray provides slow-acting relief for cluster headache attacks
This proof-of-concept trial provides “critical information and paves the way for subsequent placebo-controlled studies.”
Expert Perspective
Behavioral factors are important in migraine management
News
Are newer migraine therapies better? It depends
“Triptans will be around for a long time, but the newer medications are here to stay,”
Conference Coverage
Opioids for headache?
Two neurologists came to very difficult conclusions over whether opioids should be considered for headache treatment.